This result contrasts with the functional metabolic findings we observed in vitro and suggests that the metabolic effect of Vhl loss in cancer cells may be more complex in vivo, potentially adapting in the setting of the tumor environment and altering metabolic preferences. This evidence concerns the gene VHL and neoplasm.